Form 8-K - Current report:
SEC Accession No. 0001214659-22-012087
Filing Date
2022-10-06
Accepted
2022-10-06 17:13:31
Documents
12
Period of Report
2022-10-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 r1052208k.htm   iXBRL 8-K 27948
  Complete submission text file 0001214659-22-012087.txt   199660

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hgen-20221003.xsd EX-101.SCH 3203
3 XBRL LABEL FILE hgen-20221003_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hgen-20221003_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT r1052208k_htm.xml XML 3571
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 221298718
SIC: 2834 Pharmaceutical Preparations